Open Access

miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells

  • Authors:
    • Yu Zhang
    • Shujin He
    • Renmei Mei
    • Yurong Kang
    • Jing Duan
    • Ran Wei
    • Chuqi Xiang
    • Yemeng Wu
    • Xiangtong Lu
    • Zhenyu Cai
    • Lixia Xiong
  • View Affiliations

  • Published online on: April 4, 2018     https://doi.org/10.3892/or.2018.6352
  • Pages: 2613-2623
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

IL‑13 is a proinflammatory cytokine associated with multiple pathological conditions and the promotion of metastasis in lung cancer. Previous studies have demonstrated that IL‑13 and YY1 are associated with PI3K/AKT signaling. In addition, miR‑29a has been found to play a critical role in cell invasion in lung cancer. However, the molecular mechanism of miR‑29a underlying its involvement in IL‑13‑induced lung cancer cell invasion remains largely unknown. In the present study, we aimed to investigate the role of miR‑29a in cell invasion mediated by IL‑13 in lung cancer. By using MTT and wound‑scratch assays, we assessed cell proliferation and migration induced by IL‑13, and identified activation of the PI3K/AKT/YY1 pathway. Inhibition of PI3K/AKT by LY294002 downregulated IL‑13‑induced YY1 expression. Furthermore, we found that miR‑29a directly targets YY1 and suppressed its expression in lung cancer. By using MTT, flow cytometry and Transwell assays, overexpression of miR‑29a restricted both YY1 and N‑cadherin expression, and inhibited IL‑13‑induced invasion of lung cancer A549 cells. Taken together, these findings demonstrate that PI3K/AKT/YY1 is involved in the regulation of lung cancer cell behavior induced by IL‑13, and miR‑29a represents a promising therapeutic target.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 39 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, He S, Mei R, Kang Y, Duan J, Wei R, Xiang C, Wu Y, Lu X, Cai Z, Cai Z, et al: miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells. Oncol Rep 39: 2613-2623, 2018
APA
Zhang, Y., He, S., Mei, R., Kang, Y., Duan, J., Wei, R. ... Xiong, L. (2018). miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells. Oncology Reports, 39, 2613-2623. https://doi.org/10.3892/or.2018.6352
MLA
Zhang, Y., He, S., Mei, R., Kang, Y., Duan, J., Wei, R., Xiang, C., Wu, Y., Lu, X., Cai, Z., Xiong, L."miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells". Oncology Reports 39.6 (2018): 2613-2623.
Chicago
Zhang, Y., He, S., Mei, R., Kang, Y., Duan, J., Wei, R., Xiang, C., Wu, Y., Lu, X., Cai, Z., Xiong, L."miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells". Oncology Reports 39, no. 6 (2018): 2613-2623. https://doi.org/10.3892/or.2018.6352